Try our Advanced Search for more refined results
May 02, 2011
Track this case
2:11-cv-02523
New Jersey
Patent
Esther Salas
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Jazz Pharmaceuticals Inc. slapped a Boehringer Ingelheim Corp. subsidiary with another patent infringement suit Monday in New Jersey over its bid for approval to market a generic version of Jazz's narcolepsy treatment Xyrem.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login